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The nuclear factor N&IL6 had been suggested to be responsible for the IL-6-mediated induction of several acute-phase proteins. To obtain evidence 
for the involvement of NF-IL6 in the induction of acute-phase proteins, we introduced the NF-IL6 gene and its truncated mutant (delNFIL6) gene 
into a hepatoma cell line Hep3B. Then, we examined the effect of the overproduced NF-IL6 and delNFIL6 on the expression of haptoglobin, 
fibrinogen and albumin. As a result. basal production as well as induction OF haptoglobin by IL-6 were augmented by the expression of NF-IL6, 
whereas delNFI1~6 blocked the production of haptoglobin, fibrinogen and albumin. 
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1, INTRODUCTION 
Interleukin 6 (IL-6) is a cytokine with pleiotropic 
functions [I] and is a key mediator of the reaction regu- 
lating the expression of the genes encoding acute-phase 
proteins in the liver [Z-4], In a human hepatoma cell 
line, Hep3B, it has also been demonstrated that some 
acute-phase genes were activated at the transcriptional 
level by IL-6 [S]. However, the precise mechanisms 
through which the liver-specific expression of the acute- 
phase protein genes are coordinated uring the acute- 
phase response are currently unknown. 
turned out to be a rat homolog of NF-IL6. In addition, 
Cheng et al. cloned a cDNA for AGP/EBP (cl,-acid 
glycoprotein gene/enhancer binding protein) [I 31 and it 
was also a mouse homolog of NF-IL6. These observa- 
tions strongly suggested tht NF-IL4 was a trams-acting 
factor for some acute-phase proteins. However, it has 
not been shown whether the molecule works as a posi- 
tive truns-acting factor on the endogenous genes for 
acute phase proteins in hepatocytes. In this report, we 
strongly suggested that NF-IL6 activated the endoge- 
nous gene for haptoglobin. 
Our previous report [6] showed that IL-l-dependent 
transcriptional ctivation of the IL-6 gene was regulated 
via a 14.bp palindrome sequence at position - 150 bp 
relative to the cap site, and a novel nuclear factor (NF- 
IL6) was specifically able to recognize the sequence 161. 
The molecular cloning of the NF-IL6 gene demon- 
strated the high homology of its leucine zipper sequence 
and basic domain with a liver-specific CCA.AT/enhan- 
cer binding protein (C/EBP) [7]. 
2. MATERIALS AND METHODS 
2. I, C’kll cultuw md DNA ttwsfcctiotr 
Hep3B c+:lls [14] wcrc cultured in Dulbecco’s modified Eagle me- 
dium (DMEM) supplcmcnled with 10% fetal calf serum. 
DNA transfcctions were performed by the elcctroporation techni- 
que [5]. Stable transfcctiolls wcrc selected with 1.2 mg/mI of G418. 
After the sclcction, the transfectants wxc maintained in medium with 
0.6 rndml of G4lX. 
Cortese and his colleagues [8,9] identified the IL-& 
responsive lements (IL-6REs) in the haptoglobin, he- 
mopexin and CRP genes in Hep3B cells. We showed 
that NF-IL6 was able to bind the IL-6REs in these 
genes [lo]. Recently, Descombcs et al. reported the iso- 
lation of a gene encoding a liver-enriched transcriptio- 
nal factor (LAP) [1 I] and Poli et al. carried out the 
cloning of an IL-6-dcpendcnt DNA binding protein (IL- 
GDBP) [12]. These two molecules were the same and 
The cells (I .0x 10’ cells) were cultured in G-cm dishes for 48 h with 
or without 100 ng/ml of IL-G. The amount of acu~phasc proteins in 
the culturr! supCrnatant \WS IIW~SLIPXI by the ELISA method. 
Gorrc.rl,orrcietrce dlfr6W.‘~. Kishinroto. Inslitutc for Molecular and 
Cellular IXology, Osakn University, l-3, Yamada-ok;~. Suita, Osaka 
565, Japan, Fax: (RI) (6) 877 19.55. 
The mammalian expression vector I3CMGNco [ IG] was khlly do. 
nated by Dr f-1. KatastIyi\ttl;t (Tokyo University. Tokyo. JiIpan), A I .5 
kb fragment eontaihing lhc full protein-coding rcginti of NF-I L6 was 
inserted itlto u X/~\‘/rof site of the UCMGNco vector. The plusmid in 
which the NF-IL6 cDNA WIs inscrtcd in a scnsc oricntatian was 
nanled IJC/NFIL(I. The l.S*kb NF-IL6 cIINA fri\plj>cttt V/S digcWd 
with S/>/l and sclPligatcd for dctetion of O.S.kbp S/,/I fragment. The 
deletion mutant of the NF-IL.6 pcnc (drlNFIL.6) was inscrtcd illto the 
UCMGNco vector and the product was natnud f3C1dclff i’. This delc- 
ticin mutant lost thr rcginn f’rorn tyraxinc-40 to prolinc-204 ofNI:-IL6. 
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2.4 Prepnrntion of nuclear extract from Hep3B cells 
1 x 10’ cells of Hep3B or transfectants were suspended in I .5 ml of 
hypotonic buffer on ice. After standing on ice for 15 min, 100 ~1 of 
10% Nonidet P-40 was added and mixed vigorously. Then the suspen- 
sion was separated by centrifugation, and 200~1 of extraction buffer 
containing 0.4 M NaCl was added to the pellet. After shaking for 20 
min, a soluble fraction was collected as nuclear extract. 
2.5 Western blot analysis 
Nuclear extract was subjected to SDS-polyacrylamide gel electro- 
phoresis in a lo-20% grad&t gel under reduced condition and elec- 
trotransferred to PVDF (polyvinylidene difluoride) membrane, Trans- 
Blot (Bio-Bad). Anti-NF-IL6-peptide antiserum [7] which was made 
against the peptide, SKAKKTVDKHSDEYKIRR in the DNA-bind- 
ing domain of NF-IL6 was used as the first antibody. The alkali 
phosphatase method was used for the detection. 
2.6. Oligo-DNA binding asscty 
Oligo-HpC (SO pmol) [8] was end-labeled with biothin, mixed nu- 
clear extract from IX IO’ cells and 20 pg of poly(dI-dC)(dI-dC), and 
incubated for 10 min at room temperature. Then, 20~1 ofstreptavidin- 
agarose was added and incubated for 20 min at room temperature. It 
was washed with Tris-buffered saline/0.05% Tween-20 three times. 
The proteins binding to it were subjected to SDS-PAGE, followed by 
Western blot analysis with anti-NF-ILb-peptide antiserum. 
3. RESULTS AND DKCUSSIONS 
3.1. Trctnsfecrion of NF-IL6 and delNFIL6 in Hq3B 
cells 
In Hep3B cells, N&IL6 mRNA was constitutively 
expressed but its level was further augmented with IL-6 
treatment (data not shown). At the same time, the pro- 
duction of the acute-phase proteins, haptoglobin and 
fibrinogen were augmented, but their fashions were dif- 
ferent. Before IL-6 treatment, haptoglobin was ex- 
pressed in a small amount and its production was drasti- 
cally increased with IL-6 treatment, while fibrinogen 
was expressed fairly in untreated condition and an only 
twofold increase was observed after IL-6 treatment. The 
production of albumin was decreased in Hep3B cells 
(Fig. 1). We previously suggested that maximal tran- 
scriptional activation of NF-IL6 involved sufficient syn 
.I 
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Figa I I Pwluctien of x0mc acutsq~hsu proteins from Hcp3B cells. 
‘I’hC itlllotlllt l~fi~ClllC~~¶IliltX proteins in their culture SU~Xl%itiilltS wcrc 
mcarurcd with ELISA tncthod. Colttmt~ 1, 3 and 5 are wtrcatcd tttjd 
2. 4 iIlld G 31’C IL-&trsutcd. 
thesis of NF-IL6 and its modification to a fully active 
form [IO]. Therefore, we reasoned that overproduction 
of NF-IL6 in Wep3B cells, which expressed relatively 
low levels of NF-IL6, may lead to the transcriptional 
activation due to the increased levels of activated NF- 
BL6. En contrast, overproduction of a truncated mutant 
NF-IL6 (delNFkL6) may lead to the transcriptional 
suppression by competitive binding between the mutant 
and NF-IL6. 
As a mammalian high expression vector, we used the 
BCMGNeo [16] which carried the neomycine resistant 
gene together with the bovine papilloma viral origin of 
replication. The NF-IL6 and delNFIL6 genes were in- 
serted downstream of the cytomegalovirus promoter/ 
enhancer of the BCMGNeo vector, respectively. The 
delNFIL6 gene deleted almost all the functional domain 
of NF-IL6. Its product had binding ability to DNA but 
not the transcriptional activity (our unpublished data). 
The EJCMGNeo vectors containing the NF-IL6 and 
delNFIL6 genes were named BC/NFILG and EC/ 
delNF, respectively. The vectors, BCMGNeo, BC! 
NFILG and &G/delNF were introduced into Hep3B 
cells and stable transfectants were obtained under G418 
selection. These stable transfectants were named Hep/ 
BC, Hep/NF and Hep/del, respectively. 
The expression of the products from introduced genes 
was examined by Western blot analyses. The results of 
the representative clones from Hep/NF and &p/de1 
groups were shown in Fig. 2. In the case of Hep/NF, 44 
Da and 42 kDa bands were detected, whereas the 25 
kDa and 22 kDa band were from Hep/del. The native 
NF-IL6 in Hep3B and HepG2 cells also showed two 
faint bands at the same locations as seen in Hep/NF 
(data not shown). The reason for the appearance of two 
bands is not clarified at present. The most likely ex- 
planation for the two forms of NF-IL6 may be due to 
two different translation starting points, because the 
second methionine exists at the 24th position of NF-IL6 
46kDa- - &..,+y _+‘,C. , RPF-IL6 
30 kDa - 
21.5 kDa- 
delNFl L6 
Fig. 2. Wcstcrn blot analysis of the transfcctants. Anti-NF-IL&pep- 
tide al;i;sc’runl was used for dctcction. LiillC I, 2 und 3 arc HcplBC-I 
clone. HepiNF-l olnnc, ;IIICI l-lcpkicl-I clone. rcspcctivcly. For each 
lane, IO0 ,ug of nUckitr-C~t~itc%Cd protch \WS loadcda Arrows indicate 
NF-IL6 and dclNFIL6 products, respcctivrly. 
59 
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c. 
21.5 kDa- 
‘ini&?&@. delNFlL6 
1 % 3 
c 
Fig. 3. Production of haptoglobin from the transfectants, NeplBC, 
Hep/WF and Hep/dcl. The amount of haptoglobin in their culture 
supematants was measured by ELISA method. Numbers 1 to 9 indi- 
cate individual clones from each group of the transfectants. Panels (A) 
and (B) show the result in untreated and IL-6-teeated cases, respec- 
tively. In panel (A), the difference between Wep/BC and Nepidel was 
significant with RO.001. (C) Western blot analysis of oligo-WpC 
binding proteins with anti-NF-IL6-peptide antiserum. The method 
was described in section 2. Lanes I,2 and 3 are HeplBC-I, NepINF-1. 
and Wep/del-I clones, respectively. Arrows indicate NF-IL6 and delN- 
FIL6 products, respectively. 
and the calculated molecular weight of 23 amino acids 
corresponds with the difference of the two products. 
3.2 Effects of the expression of NF-IL6 and delNFIL4 
on acute-phase proteins 
We measured the production of haptoglobin in Hepl 
NF, Hep/BC and Hep/del. Each nine clones from them 
were used for the measurement of haptoglobin produc- 
tion. The results of ELBA for haptoglobin in their 
culture supernatants are shown in Fig. 3A. In both 
IL-6-treated and untreated cases, Hep/NF produced re- 
markably more haptoglobin than control Hep/BC 
(average, about 4-fold and g-fold higher, respectively). 
On the other hand, in both cases, Hep/del produced it 
less than control Hep/BC (average, about 60% and 40% 
less, respectively). 
To confirm the binding activity of expressed NF-IL6 
and delNF-IL6 to regulatory c&element of hapto- 
globin, we performed an oligo-DNA binding assay for 
nuclear extracts from the transfectants. As the oligo- 
DNA, we used oligo-HpC (26-mer) which was an essen- 
tial &-element for haptoglobin induction by IL-6 treat- 
ment [8], The HpC-binding proteins in the transfectants 
were assayed by Western blotting using anti-NF-IL6 
antiserum (Fig. 3C). NF-IL6 and delNFIL6-specific 
bands were observed in the lanes of Hep/NF-I and 
Hep/del-1 clones, respectively. This result indicates that 
NF-IL6 and delNFIL6, expressed in the transfectants, 
are able to bind the HpC element in vitro, and suggests 
that they directly act on the haptoglobin gene. 
The average amount of haptoglobin from untreated 
Hep/NF was about ten times less than that of control 
Hep/BC treated with IL-6 (Fig. 3A and B). These 
observations uggest wo possibilities: (1) some other 
c&elements and t,ans-acting factor may be involved in 
induction of haptoglobin, or (2) modification of NF- 
IL6 or association of other molecule(s) to NF-IL6 are 
necessary for maximal induction of haptoglobin, 
We also measured the amounts of fibrinogen and 
albumin production in nine clones from each group, 
using the same supernatnnts used for the mcasurcmcnt 
of haptoglobin production. The results of ELBA for 
fibrinogen and albumin in their culture supernalants arc 
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l_- 
untreated SE-6-tfXMit~d 
Fig. 4. Production of acute-phase proteins from the transfectants. The 
method of measurement was same as in Fig. 3A and B. Each bar 
indicates the average of nine clones from each group of the transfec- 
tants. Panels (A) and (B) indicate the production of fibrinogen and 
albumin, respectively. In panels (A) and (B), the differences between 
Hep/del and HeplBC were significant with PcO.001 and PcO.02, respec- 
tivcly. 
shown in Fig. 4. The production of fibrinogen from 
Hep/‘NF did not increase as compared to that from 
control Hep/BC. This result suggests that NF-IL6 does 
not have a strong transcriptional activity for the fibri- 
nogen genes. Hep/del produced a significantly lower 
amount of it as compared to Hep/BC and Hep/NF, 
suggesting the possibility that delNFIL6 suppressed the 
expression of it through &-elements recognized by NF- 
IL6. Although evidence that the 5’-regulatory regions of 
the fibrinogen genes contain an NF- IL6 binding motif 
has not been provided, our results suggest that cis-ele- 
ments homologous to an NF-IL6 binding motif are im- 
portant for the expression of fibronogen. 
In the albumin gene, several c&regulatory elements 
have been reported [17], and two of these elements, B 
and B, are particularly important for the liver-specific 
transcriptiom of albumin. .Gs transcription factors that 
recognized the D site, C/EBpti,an,g DJ? wer$ isolated 
[l&19]. NE-IL6 also binds to the D site f7]. we showed 
in this study that Hep/del produced less albumin than 
Hep/BC, confirming that the D site is an important 
positive &-regulatory element in the albumin expres- 
sion If NE-IL6 is a negative regulator for the albumin 
gene, the suppression of albumin production would be 
augmented in Hep/NF as compared to Hep/BC. I-IO%- 
ever, the amount of albumin produced by Hep/NF was 
comparable to that by Hep/BC. These results indicate 
that other IL-6-inducible molecule(s) which are able to 
bind tightly to the D site may be responsible for the 
transcriptional suppression of the albumin gene after 
IL-6-treatment. 
We also measured the production of a,-antitrypsin, 
the expression of which did not significantly change 
during IL-6-treatment in Mep3B cells [5]. The produc- 
tion of a,-antitrypsin did not show any significant dif- 
ference between Hepl BC, Hep/NF and Hep/del, exclud- 
ing the possibility that non-specific inhibition for prb- 
tein synthesis by Hep/del might be responsible for the 
suppression of haptoglobin, fibrinogen and albumin 
production. Furthermore, to exclude the possibility that 
IL-6 induced by NE-IL6 might be responsible for the 
above results, we examined IL-6 production in Hep/BC, 
Hep/NF and I-Iep/del. IL-6 was undetectable in these 
culture supernatants with the ELISA method (co.025 
U/ml). 
In this study, we strongly suggest that NE-IL6 
actually worked on an endogenous gene of haptoglobin 
as a positive trans-acting factor, and suggest that some 
other factors may be necessary for maximal induction 
of haptoglobin. 
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